Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone

Price, D, Henley, W, Carter, V, Skinner, D, Vella, R, Papi, A, Fabbri, L M, Kertsjens, H, Roche, N, Singh, D, Vogelmeier, C, Sen, E, Cancado, J, Nudo, E, Barile, S & Georges, G 2022, 'Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone', Respirology, vol. 27, no. S1, TO 098, pp. 81. https://doi.org/10.1111/resp.14216